Long-term incidence and timing of reactivation in patients with type 3 neovascularization after initial treatment.
Jae Hui KimYoung Suk ChangJong Woo KimChul Gu KimDong Won LeePublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2019)
In patients with type 3 neovascularization, almost all reactivation was noted within 15 months of the third anti-VEGF injection, suggesting the need for close follow-up and detailed examination during this period. Female patients with thick choroid should be monitored more frequently during this early period.